Patents by Inventor Massimo Levrero

Massimo Levrero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE CLONAL CELL LINE AS A HBV RNA STANDARD
    Publication number: 20240294880
    Abstract: The invention provides a clonal cell line derived from a liver cancer cell line, preferably derived from a Huh7 hepatocarcinoma cell line, engineered to produce and secrete viral particles containing pregenomic RNA of the hepatitis B virus (HBV), predominantly over DNA of HBV, to calibrate quantitative HBV RNA assays.
    Type: Application
    Filed: February 29, 2024
    Publication date: September 5, 2024
    Applicants: Universite Claude Bernard Lyon 1, Centre National de la Recherche Scientifique, INSERM (Institut National de la Santé et de la Recherche Médicale), Hospices Civils De Lyon, Centre Leon Berard
    Inventors: Massimo Levrero, Fabien Zoulim, Alexia Paturel
  • ALTERNATIVE USES FOR HBV ASSEMBLY EFFECTORS
    Publication number: 20150292045
    Abstract: Described herein are methods for identifying compounds useful for the treatment of infection by hepatitis B virus (HBV).
    Type: Application
    Filed: November 8, 2013
    Publication date: October 15, 2015
    Inventors: Massimo Levrero, Adam Zlotnick